Case Study
DRL-Case-Study
Moglix Enables Supply Chain Predictability and Efficiency for a COVID19 Vaccine Manufacturer
Our Client
Our client is an integrated global pharmaceutical company with interests in APIs, global generics, and proprietary products and the sole licensed partner for the first globally registered COVID19 vaccine; Sputnik V, in India. The enterprise leverages its robust supply chain to accelerate the access to 200+ medicines across 80 countries worldwide. Moglix Business is partnering with the vaccine maker for its MRO procurement requirements across its 16 manufacturing plants in India to enable continuous supply, cost-competitiveness and quality assurance.
Business Challenges
- Fragmented supplier base for MRO goods
- High inventory holding across all plants
- Volatile monthly MRO procurement spend
16
plants enabled for JIT delivery of MRO goods.
ابق على تواصلSolution
Explore how Moglix is enabling JIT delivery, replacing the non-strategic vendor codes with a single point of contact for procurement and ensuring procurement cost savings.
الأثر على مختلف المجالات
Digitize_Casestudy_Construction
Enabling agile MRO procurement at scale through workflow digitization
تحميل دراسة الحالة
Getting Indian Businesses Prepared for Restarting the Supply Chain During Lockdown 4.0
اقرأ المزيد
الحاضر والمستقبل في قطاع البنية التحتية.
Listen Now
Back